A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis.

A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis.

The predictions of two mathematical models describing the transmission dynamics of schistosome infection and the impact of mass drug administration are compared. The models differ in their description of the dynamics of the parasites within the host population and in their representation of the stag...

Full description

Bibliographic Details
Main Authors:	Truscott, J, Gurarie, D, Alsallaq, R, Toor, J, Yoon, N, Farrell, S, Turner, H, Phillips, A, Aurelio, H, Ferro, J, King, C, Anderson, R
Format:	Journal article
Language:	English
Published:	Elsevier 2017

Similar Items

A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis
by: J.E. Truscott, et al.
Published: (2017-03-01)

Are we on our way to achieving the 2020 goals for schistosomiasis morbidity control using current World Health Organization guidelines?
by: Toor, J, et al.
Published: (2018)

Are we on our way to achieving the 2020 goals for schistosomiasis morbidity control using current World Health Organization guidelines?
by: Toor, J, et al.
Published: (2018)

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
by: Toor, J, et al.
Published: (2018)

Assessing the interruption of the transmission of human helminths with mass drug administration alone: optimizing the design of cluster randomized trials.
by: Anderson, R, et al.
Published: (2017)

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni.
by: Jaspreet Toor, et al.
Published: (2018-10-01)

Comparison and validation of two mathematical models for the impact of mass drug administration on Ascaris lumbricoides and hookworm infection.
by: Coffeng, L, et al.
Published: (2017)

Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
by: Kura, K, et al.
Published: (2019)

Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines.
by: Ramzi A Alsallaq, et al.
Published: (2017-04-01)

Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations
by: Turner, H, et al.
Published: (2017)

What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?
by: RM Anderson, et al.
Published: (2015-10-01)

The past matters: estimating intrinsic hookworm transmission intensity in areas with past mass drug administration to control lymphatic filariasis
by: Werkman, M, et al.
Published: (2017)

Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission.
by: Toor, J, et al.
Published: (2019)

The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission
by: Sam H. Farrell, et al.
Published: (2017-06-01)

Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination.
by: Klodeta Kura, et al.
Published: (2019-06-01)

Economic evaluations of mass drug administration: the importance of economies of scale and scope
by: Turner, H, et al.
Published: (2017)

Comparison and validation of two mathematical models for the impact of mass drug administration on Ascaris lumbricoides and hookworm infection
by: Luc E. Coffeng, et al.
Published: (2017-03-01)

The past matters: estimating intrinsic hookworm transmission intensity in areas with past mass drug administration to control lymphatic filariasis
by: Marleen Werkman, et al.
Published: (2017-05-01)

Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa
by: David Gurarie, et al.
Published: (2015-10-01)

Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration
by: Werkman, M, et al.
Published: (2018)

Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations
by: Hugo C. Turner, et al.
Published: (2017-04-01)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
by: Kura, K, et al.
Published: (2020)

Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses
by: Turner, H, et al.
Published: (2016)

The human-snail transmission environment shapes long term schistosomiasis control outcomes: Implications for improving the accuracy of predictive modeling.
by: David Gurarie, et al.
Published: (2018-05-01)

Vaccination or mass drug administration against schistosomiasis: A hypothetical cost-effectiveness modelling comparison
by: Collyer, B, et al.
Published: (2019)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
by: Klodeta Kura, et al.
Published: (2020-11-01)

Policy implications of the potential use of a novel vaccine to prevent infection with schistosoma mansoni with or without mass drug administration
by: Kura, K, et al.
Published: (2020)

Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
by: Benjamin S. Collyer, et al.
Published: (2019-10-01)

Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration.
by: Marleen Werkman, et al.
Published: (2018-10-01)

Integration of mass drug administration programmes in Nigeria: the challenge of schistosomiasis
by: Richards Jr Frank O, et al.
Published: (2006-01-01)

Mathematical Modeling and Analysis of Transmission Dynamics and Control of Schistosomiasis
by: Ebrima Kanyi, et al.
Published: (2021-01-01)

On the mathematical modeling of schistosomiasis transmission dynamics with heterogeneous intermediate host
by: Chinwendu E. Madubueze, et al.
Published: (2022-10-01)

Modeling schistosomiasis transmission: the importance of snail population structure
by: Larissa C. Anderson, et al.
Published: (2021-02-01)

Human population movement can impede the elimination of soil-transmitted helminth transmission in regions with heterogeneity in mass drug administration coverage and transmission potential between villages: a metapopulation analysis
by: Carolin Vegvari, et al.
Published: (2019-09-01)

Planning schistosomiasis control: investigation of alternative sampling strategies for Schistosoma mansoni to target mass drug administration of praziquantel in East Africa
by: Sturrock, H, et al.
Published: (2011)

Planning schistosomiasis control: investigation of alternative sampling strategies for Schistosoma mansoni to target mass drug administration of praziquantel in East Africa.
by: Sturrock, H, et al.
Published: (2011)

Population biology of Schistosoma mating, aggregation, and transmission breakpoints: more reliable model analysis for the end-game in communities at risk.
by: David Gurarie, et al.
Published: (2014-01-01)

Control of schistosomiasis transmission
by: Luiz C. de S. Dias, et al.
Published: (1995-04-01)

A mathematical model for the seasonal transmission of schistosomiasis in the lake and marshland regions of China
by: Yingke Li, et al.
Published: (2017-09-01)

Systematic review of community-based, school-based, and combined delivery modes for reaching school-aged children in mass drug administration programs for schistosomiasis.
by: Michael Burnim, et al.
Published: (2017-10-01)